Spire Healthcare Group plc
SPI.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | £796,700 | £748,700 | £762,500 | £682,500 |
| % Growth | 6.4% | -1.8% | 11.7% | – |
| Cost of Goods Sold | £435,500 | £411,200 | £472,200 | £372,500 |
| Gross Profit | £361,200 | £337,500 | £290,300 | £310,000 |
| % Margin | 45.3% | 45.1% | 38.1% | 45.4% |
| R&D Expenses | £0 | £0 | £0 | £0 |
| G&A Expenses | £0 | £0 | £0 | £0 |
| SG&A Expenses | £0 | £0 | £223,000 | £18,600 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | £298,200 | £271,600 | £0 | £232,000 |
| Operating Expenses | £298,200 | £271,600 | £223,000 | £250,600 |
| Operating Income | £63,000 | £65,900 | £67,300 | £60,100 |
| % Margin | 7.9% | 8.8% | 8.8% | 8.8% |
| Other Income/Exp. Net | -£52,200 | -£50,300 | -£44,600 | £0 |
| Pre-Tax Income | £10,800 | £15,600 | £22,700 | £14,300 |
| Tax Expense | £3,800 | £3,700 | £8,600 | -£900 |
| Net Income | £6,500 | £12,000 | £13,400 | £14,900 |
| % Margin | 0.8% | 1.6% | 1.8% | 2.2% |
| EPS | 0.016 | 0.03 | 0.033 | 0.037 |
| % Growth | -45.6% | -10.2% | -10% | – |
| EPS Diluted | 0.016 | 0.029 | 0.032 | 0.036 |
| Weighted Avg Shares Out | 406,250 | 403,305 | 403,662 | 414,476 |
| Weighted Avg Shares Out Dil | 405,965 | 408,535 | 413,987 | 416,679 |
| Supplemental Information | – | – | – | – |
| Interest Income | £200 | £0 | £400 | -£43,600 |
| Interest Expense | £52,400 | £49,100 | £49,300 | £47,500 |
| Depreciation & Amortization | £34,000 | £37,700 | £55,800 | £53,500 |
| EBITDA | £108,700 | £105,400 | £127,800 | £115,300 |
| % Margin | 13.6% | 14.1% | 16.8% | 16.9% |